ASX Share rice
Fri 07 Aug 2020 - 08:05:am (Sydney)

CLV Share Price

CLOVER CORPORATION LIMITEDCLVMaterials

CLV Company Information

Name:

Clover Corporation Limited

Sector:

Consumer Defensive

Industry:

Packaged Foods

GIC Industry:

Chemicals

GIC Sub Industry:

Specialty Chemicals

Address:

39 Pinnacle Road Altona North VIC Australia 3025

Phone:

61 3 8347 5000

Full Time Employees:

42

CEO & MD:

Mr. Peter J. Davey MBA, gradDip Bus., GAICD

CFO & Company Sec.:

Mr. Paul A. Sherman C.A., M.B.A., B.Bus, CA, MBA

Operations Mang.:

Mr. David Pierotti

Human Resource & Payroll Mang.:

Ms. Sharon Brewster

Chief Commercial Officer:

S. Poothong

Company Overview:

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. The company is also involved in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. The company was founded in 1988 and is headquartered in Altona North, Australia.

CLV Share Price Information

Shares Issued:

166.31M

Market Capitalisation:

$369.21M

Dividend per Share:

$0.02

Ex Dividend Date:

2019-10-29

Dividend Yield:

0.90%

Revenue (TTM):

$80.04M

Revenue Per Share (TTM):

$0.48

Earnings per Share:

$0.061

Profit Margin:

0.1281

Operating Margin (TTM):

$0.17

Return On Assets (TTM):

$0.13

Return On Equity (TTM):

$0.23

Quarterly Revenue Growth (YOY):

0.098

Gross Profit(TTM):

$23.92M

Diluted Earnings Per Share (TTM):

$0.061

QuarterlyEarnings Growth(YOY):

0.026

CLV CashFlow Statement

CashFlow Date:

2019-07-31

Investments:

$-10,589,000

Change To Liabilities:

$3.94M

Total Cashflow From Investing Activities:

$-10,589,000

Net Borrowings:

$9.27M

Net Income:

$10.10M

Total Cash From Operating Activities:

$4.79M

Depreciation:

$409K

Dividends Paid:

$-3,097,000

Change To Inventory:

$-7,913,000

Change To Account Receivables:

$-3,189,000

Capital Expenditures:

$108K

CLV Income Statement

Income Date:

2019-07-31

Income Before Tax:

$13.96M

Net Income:

$10.10M

Gross Profit:

$23.92M

Operating Income:

$13.59M

Interest Expense:

$330K

Income Tax Expense:

$3.86M

Total Revenue:

$76.68M

Total Operating Expenses:

$10.33M

Cost Of Revenue:

$52.76M

CLV Balance Sheet

Balance Sheet Date:

2019-07-31

Intangible Assets:

$1.91M

Total Liabilities:

$29.61M

Total Stockholder Equity:

$45.14M

Other Current Liabilities:

$7.52M

Total Assets:

$74.75M

Common Stock:

$32.92M

Retained Earnings:

$12.39M

Other Liabilities:

$61K

Good Will:

$1.91M

Other Assets:

$1.25M

Cash:

$8.27M

Total Current Liabilities:

$17.56M

Short-Term Debt:

$1.47M

Property - Plant & Equipment:

$5.78M

Net Tangible Assets:

$43.23M

Long-Term Investments:

$10.46M

Total Current Assets:

$55.36M

Long-Term Debt:

$11.99M

Net Receivables:

$17.43M

Short-Term Investments:

$19.40M

Inventory:

$27.68M

Accounts Payable:

$7.97M

Non Currrent Assets (Other):

$19.40M

Short-Term Investments:

$19.40

Non Current Liabilities Total:

$12.05M

CLV Share Price History

CLV News

30 Jul, 2020
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the second quarter ended June 30, 2020.
16 Jul, 2020
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company will release its second quarter 2020 financial results on Thursday, July 30, 2020 before the U.S. financial markets open. Management will host a conference call and webcast to review the results and provide a corporate update at 8:30 AM ET.
14 Jul, 2020
If you want to know who really controls Clover Corporation Limited (ASX:CLV), then you'll have to look at the makeup...
26 Apr, 2020
Today we'll evaluate Clover Corporation Limited (ASX:CLV) to determine whether it could have potential as an...
27 Mar, 2020
The analysts might have been a bit too bullish on Clover Corporation Limited (ASX:CLV), given that the company fell...
16 Mar, 2020
To the annoyance of some shareholders, Clover (ASX:CLV) shares are down a considerable 33% in the last month. Looking...
03 Feb, 2020
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
02 Jan, 2020
Peter Davey became the CEO of Clover Corporation Limited (ASX:CLV) in 2014. First, this article will compare CEO...
04 Dec, 2019
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
15 Nov, 2019
If you're interested in Clover Corporation Limited (ASX:CLV), then you might want to consider its beta (a measure of...
11 Oct, 2019
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
26 Sep, 2019
Clover (ASX:CLV) shares have continued recent momentum with a 32% gain in the last month alone. Looking back a bit...
20 Sep, 2019
The big shareholder groups in Clover Corporation Limited (ASX:CLV) have power over the company. Institutions often own...
04 Sep, 2019
Clover Corporation Limited (ASX:CLV) is a company with exceptional fundamental characteristics. Upon building up an...
21 Aug, 2019
Clover Corporation Limited (ASX:CLV), which is in the chemicals business, and is based in Australia, saw a...

CLV Dividend Payments

EX-Date Dividend Amount
2010-11-28$0.0125
2011-10-26$0.0150
2012-10-25$0.0175
2013-04-16$0.0050
2013-10-24$0.0150
2014-04-16$0.0050
2014-10-28$0.0050
2015-10-27$0.0050
2016-04-11$0.0025
2016-10-26$0.0050
2017-04-10$0.0025
2017-10-26$0.0075
2018-04-09$0.0050
2018-10-28$0.0125
2019-04-08$0.0063
2019-10-28$0.0175

CLV Dividends (last 10 Years)